Previous Article | Next Article ![]()
Journal of Virology, July 2006, p. 7028-7036, Vol. 80, No. 14
0022-538X/06/$08.00+0 doi:10.1128/JVI.00478-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Michael Robek,2 and
John K. Rose2*
Section of Microbial Pathogenesis,1 Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 065102
Received 7 March 2006/ Accepted 27 April 2006
Vesicular stomatitis virus (VSV) matrix (M) protein blocks host mRNA export from the nucleus and thereby inhibits interferon induction in infected cells. M mutants with mutations of methionine 51 (M51) lack this shutoff function. We examined pathogenesis of a VSV M mutant with a deletion of M51 (VSV
M51) after intranasal infection of BALB/c mice and found an unexpected phenotype. Mice that received VSV
M51 experienced a more rapid but overall less severe weight loss than mice that received the recombinant wild-type VSV (rwtVSV). Rapid weight loss was not explained by faster initial replication because VSV
M51 replication was controlled faster than rwtVSV replication in the lungs and did not spread systemically like rwtVSV. This faster control of VSV
M51 correlated with a more rapid induction of interferon in the lung. Because tumor necrosis factor alpha (TNF-
) is associated with weight loss, we examined TNF-
induction in mice infected with rwtVSV or VSV
M51. We found more-rapid induction of TNF-
by the mutant at early times after infection, while rwtVSV induced more TNF-
later in infection. This result suggested that TNF-
induction might explain both the rapid weight loss caused by the mutant and the overall greater weight loss caused by the rwtVSV. Using TNF-
knockout mice (C57BL/6 background), we showed that weight loss following rwtVSV infection was greatly reduced in the absence of TNF-
. Although the rapid weight loss caused by VSV
M51 was less pronounced in C57BL/6 mice, it was eliminated in the absence of TNF-
. These results indicate a role for TNF-
in the pathogenesis of VSV.
Present address: Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|